SCI/PUBMED gelistet | alle Publikationstypen | Gesamt nach Jahr und Erstautor | MUG-Autor*innen |
** = Publikationen gelistet in SCI/SSCI/Pubmed
** Aberger, S; Schuller, M; Mooslechner, AA; Klötzer, KA; Prietl, B; Pfeifer, V; Kirsch, AH; Rosenkranz, AR; Artinger, K; Eller, K
T cell Activation Marker HLA-DR Reflects Tacrolimus-Associated Immunosuppressive Burden and BK Viremia Risk After Kidney Transplantation - An Observational Cohort Study.
Transpl Int. 2025; 38:14443
Doi: 10.3389/ti.2025.14443
[OPEN ACCESS]
PubMed
FullText
FullText_MUG
** Berghoff, AS; Mair, MJ; Spiró, Z; Abdel, Malak, C; El-Heliebi, A; Eckert, F; Furtner, J; König, F; Leibetseder, A; Nowosielski, M; Oberndorfer, S; Prietl, B; Pichler, J; Pieber, TR; Spiegl-Kreinecker, S; Urbanic, Purkart, T; Wöhrer, A; Widhalm, G; Preusser, M, , ATTRACT, study, group,
Personalized targeted glioblastoma therapies by ex vivo drug screening: Study protocol of the Advanced brain Tumor TheRApy Clinical Trial (ATTRACT).
Neurooncol Adv. 2025; 7(1):vdaf056
Doi: 10.1093/noajnl/vdaf056
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Bordag, N; Nagy, BM; Zügner, E; Ludwig, H; Foris, V; Nagaraj, C; Biasin, V; Kovacs, G; Kneidinger, N; Bodenhofer, U; Magnes, C; Maron, BA; Ulrich, S; Lange, TJ; Eichmann, TO; Hoetzenecker, K; Pieber, T; Olschewski, H; Olschewski, A
Lipid Ratios for Diagnosis and Prognosis of Pulmonary Hypertension.
Am J Respir Crit Care Med. 2025; 211(7):1264-1276
Doi: 10.1164/rccm.202407-1345OC
[OPEN ACCESS]
PubMed
FullText
FullText_MUG
** Kipper, JA; Wiener, M; Horvath, A; Haidacher, F; Lackner, S; Holasek, S; Ramirez-Obermayer, A; Bengesser, S; Baranyi, A; Lahousen-Luxenberger, T; Leitner, M; Butler, MI; Wagner-Skacel, J; Mörkl, S
Beyond the surface: gut microbiome and implicit learning in anorexia nervosa - A pilot study
J PSYCHOSOM RES. 2025; 194: 112164
Doi: 10.1016/j.jpsychores.2025.112164
Web of Science
PubMed
FullText
FullText_MUG
** Nonn, O; Debnath, O; Valdes, DS; Sallinger, K; Secener, AK; Fischer, C; Tiesmeyer, S; Nimo, J; Kuenzer, T; Ulrich, J; Maxian, T; Knöfler, M; Karau, P; Bartolomaeus, H; Kroneis, T; Frolova, A; Neuper, L; Haase, N; Malt, A; Müller-Bötticher, N; Kräker, K; Kedziora, S; Forstner, D; Eils, R; Schmidt-Ullrich, R; Haider, S; Verlohren, S; Stern, C; Sugulle, M; Jones, S; Thilaganathan, B; Kaitu'u-Lino, TJ; Tong, S; Huppertz, B; El-Heliebi, A; Staff, AC; Coscia, F; Müller, DN; Dechend, R; Gauster, M; Ishaque, N; Herse, F
Senescent Syncytiotrophoblast Secretion During Early Onset Preeclampsia.
Hypertension. 2025; 82(5):787-799
Doi: 10.1161/HYPERTENSIONAHA.124.23362
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Noorizadeh, R; Sax, B; Javaheri, T; Radic-Sarikas, B; Fock, V; Suresh, V; Kauer, M; Bykov, A; Kurija, D; Schlederer, M; Kenner, L; Weber, G; Mikulits, W; Halbritter, F; Moriggl, R; Kovar, H; Mikulits, W; Halbritter, F; Moriggl, R; Kovar, H
YAP1 is a key regulator of EWS::FLI1-dependent malignant transformation upon IGF-1-mediated reprogramming of bone mesenchymal stem cells
CELL REP. 2025; 44(3): 115381
Doi: 10.1016/j.celrep.2025.115381
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Pammer, A; Madl, T; Habisch, H; Kerbl-Knapp, J; Rainer, F; Stadlbauer, V; Horvath, A; Douschan, P; Stauber, RE; Marsche, G
Depletion of Small HDL Subclasses Predicts Poor Survival in Liver Cirrhosis.
Antioxidants (Basel). 2025; 14(6): 664
Doi: 10.3390/antiox14060664
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Pušeljić, M; Stadlbauer, V; Ahmadova, N; Pohl, M; Kopetzky, M; Kaufmann-Bühler, AK; Watzinger, N; Igrec, J; Fuchsjäger, M; Talakić, E
Impact of body fat composition on liver iron overload severity in hemochromatosis: a retrospective MRI analysis.
Radiol Med. 2025; 130(2):179-189
Doi: 10.1007/s11547-024-01930-8
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Rotta, G; Achille, V; Bornheimer, SJ; Duenas, M; Fernandez, M; Gatti, A; Giron, SH; Rio, IM; Massanella, M; Jiménez, DJ; Monserrat, J; Pfeifer, V; Pichler, J; Prietl, B; Sourij, H; Uras, CRM; Vlah, S; Fenoglio, D
Protocol for flow cytometry immunophenotyping of human antigen-specific T cells by activation-induced marker and Th1 cytokine detection.
STAR Protoc. 2025; 6(1):103343
Doi: 10.1016/j.xpro.2024.103343
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Woltsche, J; Pacher-Deutsch, C; Fürst, S; Gulden, L; Schwarzl, J; Feldbacher, N; Nepel, M; Celcer, L; Hasl, N; Rieper, V; Stadlbauer, V; Horvath, A
Microbial Dysbiosis in the Urinary Microbiome of Patients with Cirrhosis.
Am J Gastroenterol. 2025;
Doi: 10.14309/ajg.0000000000003634
PubMed
FullText
FullText_MUG
** Horvath, A; Habich, D; Feldbacher, N; Celcer, L; Stadlbauer, V
L-ornithine-L-aspertate improves quality of life and ammonia levels but not microbiome dysbiosis in cirrhosis: results of a phase 4 study
J HEPATOL. 2025; 82:
Web of Science